December 19, 2016
Innate Pharma picks AstraZeneca’s oncology specialist Mondher Mahjoubi
Innate Pharma has announced key leadership team and Board changes which will take effect on December 30th, 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
December 19, 2016
Veloxis increases capital by 1,5M new shares
Danish pharmaceutical company Veloxis Pharmaceuticals A/S, has increased its capital by 1,500,000 new shares. The company said on Monday that…
December 19, 2016
Chinese AceCGT bags distribution deal with Belgian MDxHealth for prostate cancer assay in Hong Kong and Macao
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…
December 16, 2016
Mylan Launches generic for EpiPen adrenaline injection, fights rising US drug prices
Mylan is launching its generic for EpiPen adrenaline injection at a wholesale acquisition cost (WAC) of $300 per epinephrine injection. As…
December 16, 2016
ABIVAX welcomes Didier Blondel as CFO
ABIVAX has appointed Didier Blondel as Chief Financial Officer, effective January 2nd, 2017.
December 16, 2016
Novartis buys Ziarco Group
Novartis has entered into a definitive agreement to buy a privately held company Ziarco Group Limited, focused on producing dermatology…
December 16, 2016
MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory
MDxHealth’s laboratory in Nijmegen, The Netherlands has received ISO 13485:2016 certification for the design, development, manufacture and distribution of in…
December 16, 2016
Allergan’s subsidiaries Forest to pay $38M for bad marketing practices
Allergan’s indirect subsidiaries Forest Laboratories, LLS and Forest Pharmaceuticals, Inc. are about to pay $38 million for bad sales and…
December 16, 2016
Valneva closes private placement in connection with EUR15.2m investment by MVM
French vaccines developer Valneva has closed the share issuance in connection with MVM Life Science Partners LLP`s investment in the…
December 15, 2016
TiGenix raises $35.65M proceeds with NASDAQ IPO
A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…